Patent applications filed
Know-how based
Licensee
Development partner
Commercial partner
Microfluidic devices are becoming widely used analytical tools for a variety of applications. These devices have numerous advantages and are creating new opportunities to advance research methods and capabilities.
Researchers at Saint Louis University have developed a microfluidic cell-on-a-chip bioreactor that enables in vitro cell culture on an extracellular matrix-resembling three dimensional (3D) scaffold and cell studies under flow conditions. This bioreactor mimics in vivo microenvironments and allows long-term solution circulation, which can be used as a miniaturized perfusion-based bioreactor.
The potential benefits of this technology include:
Increasing reliability of results from in vitro cell and tissue studies
Minimizing the cost of cell and tissue studies
Minimizing the cost of fabricating microfluidic devices
Minimizing the complexity of the fabrication process
Minimizing the fragility of microfluidic devices
Minimizing the difficulty of connecting microfluidic devices with other devices and instruments
Minimizing the amount of waste produced
The potential applications of this technology include:
Pharmaceutical studies
Pharmacodynamics (PD) and pharmacokinetics (PK) studies
Drug discovery
Drug toxicity assessments
Routine laboratory investigations
Cell and tissue culture substrates for research laboratories
Saint Louis University is seeking partners to further develop and commercialize this technology.